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Abstract 
Intracranial dural arteriovenous fistulae 
(DAVF) with retrograde cortical venous 
drainage are uncommon lesions frequently 
associated with a poor prognosis if left 
untreated. The treatment of DAVFs with 
cortical venous drainage by endovascular 
occlusion of the entire arterial supply or the 
venous drainage is considered curative. We 
present our first endovascular experience 
with use of Onyx via the arterial route in 
these aggressive fistulas. 
Key words: dural arteriovenous fistulae; 
Onyx embolization 
Introduction 
Cerebral vascular malformations like 
intracranial dural arteriovenous fistulas 
(DAVFs) are considered today dangerous 
lesions if left untreated, especially those 
with retrograde cortical venous drainage. 
Because the natural history of untreated 
lesions is frequently associated with a poor 
prognosis, prompt treatment is indicated. 
Dural arteriovenous fistulas are 
considered abnormal direct connection 
(fistula) between multiple meningeal 
arteries (arterial feeders) and a meningeal 
vein or dural venous sinus.  
The treatment of DAVFs with cortical 
venous drainage consist in occlusion of the 
all arterial supply or the venous drainage 
and can be done surgically, endovascularly, 
or by a combination of both approaches. 
Endovascular treatment of total occlusion 
of a DAVF using a transarterial 
embolization it’s difficult as a result of this 
extreme rich anastomotic network of the 
dural/falcine plethora of feeding arteries, 
blood supply to cranial nerves, and extra- 
intracranial anastomoses [1]. Transvenous 
occlusion of the affected venous sinus could 
be effective in selected cases, especially 
when the venous sinus did not drain into 
cortical or deep veins.  
The endovascular occlusion of DAVFs 
via an arterial or venous route has usually 
included embolization with acrylic glue, 
particles, coils, or a combination. Today, 
the use of Onyx (ev3, Irvine, California) via 
the arterial route has been reported as the 
optimal treatment choice. Due to its longer 
precipitation time enabling prolonged 
injection time, the Onyx offer a better 
penetration into a fistulous network. We 
report our initial experience with arterial 
injection of Onyx in the endovascular 
treatment of a DAVF with retrograde 
cortical. 
Technical procedure 
For a complete cure, the endovascular 
treatment is considered the primary 
modality of treatment of all DAVFs at most 
neurosurgical center. The liquid embolic 
agent, ONYX 18 (ethylene vinyl alcohol 
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copolymer, ev3), is usually used for 
treatment of the patients with these lesions.  
The procedure is performed with the 
patient under general anesthesia on a 
biplane angiographic unit (Axion Artis; 
Siemens Medical Solutions, Erlangen, 
Germany).  
Unilateral or bilateral transfemoral 
approach involving the use of 5F–6F 
introducing sheaths permutes arterial 
catheterization.  Standard coaxial 
techniques ensure a secure guiding and 
control catheters positioning in the 
external, internal carotid or vertebral 
arteries. The guiding catheter is continuous 
flushing with saline solution for prevention 
of tromboembolic events.  
At the beginning a six-vessel complete 
selective angiography is performed to 
precisely determine the anatomic 
characteristics of the shunt, to obtain an 
optimal projection and to plan the 
treatment. After the diagnostic angiography 
was concluded, a 5F guiding catheter was 
used for the external carotid artery (ECA) 
and 6F MPC Envoy guide catheter (Cordis 
Endovascular, Miami Lakes, Fla) for the 
internal carotid artery (ICA) and vertebral 
artery (VA) 6F) catheterization. An 
intravenous bolus of 5000 IU loading dose 
of heparin is administered to patient after 
guiding catheter placement and 1000 units 
per hour thereafter.  
Superselective catheterization of the 
predominant feeding artery using a 
dimethyl-sulfoxide (DMSO) compatible 
microcatheter (Marathon, EV3, Irvine, CA) 
(UltraFlow, Marathon, or Echelon, ev3) 
coaxially advanced on a 0.008 inch 
microguidewire (Mirage or X-Pedion, ev3) 
is performed to reach the distal aspect of the 
pedicle supplying the DAVF as close as 
possible to the fistula. Microcatheter 
angiography is then performed to confirm 
optimal position and to see the drainage of 
the fistula. Special attention is taken to 
ensure that the distal tip of the catheter is in 
a straight segment of the feeding artery to 
facilitate catheter retrieval. The 
microcatheter is less likely to stick when 
placed in a straight rather than a tortuous 
segment of the vessel.  
The microcatheter is then flushed with 
10 mL of normal saline and its “dead space” 
is subsequently filled with 0.25 mL of 
DMSO, and the microcatheter hub is 
bathed with DMSO forming a meniscus. 
Onyx and dimethyl-sulfoxide (DMSO) are 
drawn into 2 separate 1-mL syringes. 
DMSO is injected slowly over 40 sec. 
The Onyx vial is shaken on the Onyx 
mixer for at least 20 min prior to its use. 
Then, Onyx 18 is slowly injected, initially 
0.2 mL/s, without guidance, over 
approximately 40 seconds to avoid a rapid 
bolus of DMSO in the cerebral circulation. 
Subsequently under subtraction 
fluoroscopy or biplane roadmap guidance 
Onyx injection is then slowly carried out 
using a “thumb-tapping” technique. In case 
of high flow fistulas a higher viscosity Onyx 
34 it better to be chose because the higher 
viscosity agent is felt to less likely pass 
through the fistulous connection. Later in 
the course of the injection, once flow 
through the fistula is reduced, lower 
viscosity Onyx 18 is used to facilitate 
greater penetration of the nidus of the 
fistula (figure 1 A, B). 
Special attention is paid to maintain a 
gradual and progressive injection rate, while 
looking for any reflux of the embolizing 
agent, which would signal the surgeon to 
interrupt the injection.  
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Figure 1: A - microcatheterization of the DAVF; B – 
Onyx occlusion of DAVF [12] 
 
If Onyx penetrated the network of 
arterial feeders, the injection is continued 
until we suspected any of the three danger 
signs: 1) penetration of Onyx into a cortical 
vein 2) when there is any reflux around the 
catheter tip or 3) if there is retrograde filling 
into pial feeder. In these situations we abort 
the injection for 30s to 120s to allow 
solidification of Onyx in an attempt to 
change the direction of penetration in the 
network of interconnecting feeders. 
Usually, reflux occurred several times 
before Onyx would advance into the fistula 
site. A small amount of initial reflux is 
allowed, as it typically leads to the 
formation of a “plug,” which may 
subsequently facilitate antegrade flow of the 
embolic agent. Excessive reflux, however, is 
avoided, since it may lead to the occlusion 
of normal vessels or make the 
microcatheter removal more difficult. The 
normal length of tolerated reflux is between 
1.5 and 3 cm, depending on the vascular 
territory. In some cases with middle 
meningeal artery injection, more than a 5-
cm reflux was accepted. In other particular 
cases a feeding artery could be blocked with 
a microballoon (HyperForm, ev3) to 
prevent reflux and promote advancement of 
Onyx into the target sinus. Protective 
balloons should be used in cases with high-
flow DAVFs with large supplies from the 
vertebal or the internal carotid arteries. 
Flow control can be achieved with manual 
compression of the carotids or both the 
jugular vein and the carotid, or by balloon 
occlusion of the venous sinus. 
Using this "waiting technique" to change 
the direction of filling of the fistula when a 
dangerous sign is identified is crucial to 
achieve complete obliteration of the fistula. 
Whenever reflux appears, injection is 
stopped for sometime. When restarting the 
injection, it was helpful to employ roadmap 
techniques to rapidly identify the new site 
of Onyx delivery to ensure a safe 
embolization.  
The procedure is considered terminated 
when reflux recurred and persisted and no 
Onyx is entering the fistula feeding 
network or when angiography shows a 
complete fistula occlusion. The 
microcatheter is then pulled gently until it 
detached from their Onyx cast. Ultraflow 
microcatheters (ev3) could be stretched 
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until rupture in their distal flexible end, if 
they did not move. Marathon 
microcatheters (ev3) are braided and stiffer, 
allowing much more force for retrieval 
before rupture could occur. 
Patients are heparinized over 24–48 h 
and eventually kept on low molecular 
weight heparins for 1–2 weeks when we 
observed slowing down of territorial venous 
outflow or contrast stasis in various cortical 
veins. 
Case report 
A 57 year-old woman presented in 
December 2012 for an episode of speech 
disturbances and right temporal 
hemianopsia. The patient declares a history 
of ten years of a sincron noise in the left ear 
associated with retroauricular throbbing 
pain.  She was diagnosed in March 2012 
with breast carcinoma and operated by total 
left mastectomy followed by chemotherapy 
and radiotherapy. 
Neurological examination was normal 
except for pulsatile tinnitus. The patient 
initially underwent cerebral CT scan with 
enhancement that revealed low-density 
areas in left hemisphere regions, with 
several punctiform or vermicular 
enhancements (figure 2). 
Digital Subtraction Angiography showed 
a dural fistula with supply from the 
tentorial artery, posterior auricular artery, 
middle meningeal artery, and occipital 
artery and draining into a left sigmoid sinus 
with multiple venous ecstasies in the left 
cerebral hemisphere (figure 3). 
 
 
Figure 2 CT scan with several punctiform or 
vermicular enhancements 
 
 
Figure 3 DSA showing a DAVF with cortical vein 
drainage 
 
 
Figure 4  DSA image with Onyx migration showing 
the perforation of microcatheter 
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Figure 5 Postprocedural angiography showing 
DAVF complete occlusion 
 
The patient initially underwent a left 
middle meningeal artery branch approach. 
When the DMSO injection was performed 
a perforation of the microcatheter occurs 
due to a high pressure injection. The 
perforation of microcatheter was visualized 
when the injection of Onyx was started and 
the glue migrated into the artery at the 
perforations sites. The injection was 
stopped with the retrieve of the 
microcatheter (figure 4). The posterior 
auricular branch was microcatheterized and 
the DAVF (fistula segment of left sigmoid 
sinus) was completely occluded with Onyx. 
Complete occlusion of the DAVF is 
confirmed by postprocedural angiography 
(figure 5). The patient was discharged seven 
day later with no neurological deficit.   
Discussion 
The relationships between intracranial 
dural arteriovenous fistula, venous drainage 
patterns and clinical presentation were 
already presented in several studies. Many 
researchers have attempted to identify the 
factors that predispose to the risk of 
aggressive DAVF symptoms. On the basis 
of their findings, it is now generally 
accepted that the venous drainage pattern of 
DAVFs is the most predictive factor.[5] 
Intracranial DAVFs with retrograde cortical 
venous drainage are more aggressive lesions 
that have shown a much higher incidence 
of hemorrhage or venous infarction. 
Usually, these lesions can present with 
intracranial hemorrhage, seizures, 
progressive neurologic deficit, intracranial 
hypertension, or dementia. Although 
several classification systems have been 
developed to grade the risks of DAVFs, 
those devised by Cognard et al and Borden 
et al are the most widely used.[5] 
General approaches for the treatment of 
DAVFs include conservative treatment, 
radiation therapy, endovascular 
intervention, and surgery. Treatment 
option is dependent on the grade of fistula 
and the clinical picture. In selected cases as 
DAVF without angiographic evidence of 
retrograde sinus or cortical venous drainage 
and presenting with a well-tolerated or 
non-disabling tinnitus conservative 
treatment can be effective. The simple 
carotid artery or occipital artery manual 
compression has been reported to 
occasionally lead to DAVFs obliteration. 
Also, this may correspond to the natural 
history of the disease.  
The most frequently treatment of such 
fistulas primarily involves an endovascular 
approach, and if this fails, surgical or 
radiosurgical approaches are used. Also, the 
combination of them is sometime an 
option.  
Transarterial embolization of DAVF 
with embolic materials such as NBCA, 
ethanol, coils, and particles didn’t bring 
satisfactory results especially for extensive 
lesions because only large feeding artery can 
be occluded.  Incomplete occlusion of the 
fistulas will result in recanalization of the 
DAVF from the multiple collateral arteries 
constituting the dural blood supply[1]. 
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Onyx™ (ev3, Irvine, CA, USA) is a 
liquid embolic material that is increasingly 
used via the arterial route in embolization 
of arteriovenous malformations. Its 
properties of longer precipitation time 
enabling prolonged injection time, with 
potential of better penetration into a 
fistulous network make Onyx the best 
option for complete DAVFs occlusion.  
Onyx treatment for DAVFs with cortical 
venous drainage is encouraging and our 
case presentation confirms the good results 
reported recently by other authors [6]. 
The complications reported in the 
literature were the bleeding after 
incomplete occlusion, cerebral ischemia 
due to venous thrombosis and ischemic 
damage to the trigeminal and facial nerves. 
Damage to these nerves may occur if Onyx 
reflux extends proximally to the foramen 
spinosum level and occludes the cavernous 
and petrosal branches.[6] 
The annual mortality rate for cortical 
venous reflux may be as high as 10.4%, 
whereas the annual risk for hemorrhage or 
nonhemorrhagic neurologic deficits during 
follow-up are 8.1% and 6.9%, respectively, 
resulting in an annual event rate of 15%.[3] 
 
Conclusions 
A better understanding of factors as 
drainage patterns, risk of aggressive 
symptoms and feasibility of recent technical 
advances is essential for the treatment of 
DAVFs. Onyx embolization has 
revolutionised the endovascular treatment 
of DAVFs and become the primary 
treatment option for most cases. Despite 
achieving a higher cure rates in single 
session with minimal complication, larger 
number of cases and longer follow up are 
required to determine the efficacy and 
safety of this technique. 
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